메뉴 건너뛰기




Volumn 25, Issue 8, 2004, Pages 623-625

Treating electrical instability in sudden cardiac death survivors - Are we looking at the right side of the coin?

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POLYUNSATURATED FATTY ACID;

EID: 2342629351     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.02.029     Document Type: Editorial
Times cited : (2)

References (7)
  • 1
    • 17944381537 scopus 로고    scopus 로고
    • Task force on sudden cardiac death of the European Society of Cardiology
    • Priori SG, Aliot E, Blomstrom-Lundqvist C et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001;22:1374-450.
    • (2001) Eur Heart J , vol.22 , pp. 1374-1450
    • Priori, S.G.1    Aliot, E.2    Blomstrom-Lundqvist, C.3
  • 2
    • 2342593368 scopus 로고    scopus 로고
    • Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomized assignment to implantable defibrillator or antiarrhythmic therapy
    • Capato R, Boczor S, Kuck KH on behalf of the CASH investigators. Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomized assignment to implantable defibrillator or antiarrhythmic therapy. Eur Heart J 2004;25:642-649.
    • (2004) Eur Heart J , vol.25 , pp. 642-649
    • Capato, R.1    Boczor, S.2    Kuck, K.H.3
  • 3
    • 0033212981 scopus 로고    scopus 로고
    • Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics versus implantable defibrillators
    • Domanski MJ, Sakseena S, Epstein AE et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics versus implantable defibrillators. J Am Coll Cardiol 1999;34(4):1090-5.
    • (1999) J Am Coll Cardiol , vol.34 , Issue.4 , pp. 1090-1095
    • Domanski, M.J.1    Sakseena, S.2    Epstein, A.E.3
  • 4
    • 0034636059 scopus 로고    scopus 로고
    • Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian implantable defibrillator study
    • Sheldon R, Connolly S, Krahn A et al. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian implantable defibrillator study. Circulation 2000;101:1660-4.
    • (2000) Circulation , vol.101 , pp. 1660-1664
    • Sheldon, R.1    Connolly, S.2    Krahn, A.3
  • 6
    • 0034602819 scopus 로고    scopus 로고
    • Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death
    • Teerlink JR, Jalaluddin M, Anderson S. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 2000;101:40-6.
    • (2000) Circulation , vol.101 , pp. 40-46
    • Teerlink, J.R.1    Jalaluddin, M.2    Anderson, S.3
  • 7
    • 0037432303 scopus 로고    scopus 로고
    • Drug therapy and heart failure prevention
    • Linseman JV, Bristow MR. Drug therapy and heart failure prevention. Circulation 2003;107:1234-6.
    • (2003) Circulation , vol.107 , pp. 1234-1236
    • Linseman, J.V.1    Bristow, M.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.